Integra LifeSciences Holdings Corporation (IART) - Financial and Strategic SWOT Analysis Review

Document Sample
Integra LifeSciences Holdings Corporation (IART) - Financial and Strategic SWOT Analysis Review Powered By Docstoc
					               Integra LifeSciences Holdings Corporation (IART) - Financial and
                               Strategic SWOT Analysis Review

       Reference Code: GDME717FSA                                                                                         Publication Date: DEC 2010

       311 Enterprise Drive                      Phone               +1 609 2750500                     Revenue           682.5 (million USD)
       Plainsboro, NJ                            Fax                 +1 609 2755363                     Net Profit        50.96 (million USD)
       08536                                     Website             www.integra-ls.com                 Employees         3,000
       United States                             Exchange            IART [NASDAQ]                      Industry          Medical Equipment

      Company Overview
       Integra LifeSciences Holdings Corporation (Integra) is one of the world’s leading innovative medical device companies, focused
       on the development, manufacture and marketing of devices for use in cranial and spinal procedures, peripheral nerve repair,
       small bone and joint injuries, and the repair and reconstruction of soft tissue. The company has three business divisions, namely,
       Integra NeuroSciences, Integra Orthopedics and Integra Medical Instruments. The company is an innovative medical device
       company focused on helping the medical professionals to enhance the standards of care.

      Key Executives                                                                   SWOT Analysis
                     Name                                    Title                     Integra LifeSciences Holdings Corporation, SWOT
                                                                                       Analysis
       Stuart M. Essig                       Chief Executive Officer
                                                                                       Strengths                   Weaknesses
       Richard E. Caruso Ph.D.               Chairman
       Thomas J. Baltimore, Jr.              Director                                  Sales and Distribution             Raw Materials Derived from
                                                                                       Network                            Animal Sources
       Keith Bradley Ph.D.                   Director
       Neal Moszkowski                       Director                                  Diversified Product Base           Reliance on the US Market
       Source: Annual Report, Company Website, Primary and Secondary Research,
       GlobalData

      Share Data
                                                                                       Opportunities                      Threats
       Integra LifeSciences Holdings Corporation
       Share Price (USD) as on 17-Dec-2010                                 49.70       Strategic Acquisitions and         Highly Competitive Market
                                                                                       Agreements
       EPS (USD)                                                             1.74
                                                                                                                          Cost Containment Pressures
       Market Cap (million USD)                                            1,405       Product Launches
       Enterprise Value (million USD)                                      1,695

       Shares Outstanding (million)                                               28
                                                                                       Source: Annual Report, Company Website, Primary and Secondary
       Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                       Research, GlobalData
       GlobalData

      Financial Performance                                                            Recent Developments
                                                                                       Nov 01, 2010        Integra Signs Multi-Year Contracts With
                                                                                                           Broadlane To Provide Dural Substitute,
                                                                                                           Neuro Trauma And Hydrocephalus
                                                                                                           Products
                                                                                       Oct 28, 2010        Integra LifeSciences Reports Net Income
                                                                                                           Of $16.48 Million For Q3 2010
                                                                                       Oct 14, 2010        Integra Launches New Corporate Identity
                                                                                                           At Neurological Surgeons Annual Meeting
                                                                                       Oct 12, 2010        Integra Appoints Peter J. Arduini As
                                                                                                           President, COO
        Source: Annual Report, Company Website, Primary and Secondary Research,        Oct 05, 2010        Integra To Offer Four Workshops At ASSH
        GlobalData
                                                                                       Source: Annual Report, Company Website, Primary and Secondary
                                                                                       Research, GlobalData




Integra LifeSciences Holdings Corporation (IART) - Financial and Strategic                                                          Reference Code: GDME717FSA
SWOT Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                              Page 1
      Ta b le o f Co n te n ts
      Table of Contents ..................................................................................................................................................................................................... 2
      List of Tables ............................................................................................................................................................................................................ 4
      List of Figures ........................................................................................................................................................................................................... 4
      Section 1 - About the Company ................................................................................................................................................................................ 5
      Integra LifeSciences Holdings Corporation - Key Facts ............................................................................................................................................ 5
      Integra LifeSciences Holdings Corporation - Key Employees.................................................................................................................................... 6
      Integra LifeSciences Holdings Corporation - Key Employee Biographies .................................................................................................................. 7
      Integra LifeSciences Holdings Corporation - Major Products and Services ............................................................................................................... 8
      Integra LifeSciences Holdings Corporation - History ................................................................................................................................................12
      Integra LifeSciences Holdings Corporation - Company Statement ...........................................................................................................................14
      Integra LifeSciences Holdings Corporation - Locations And Subsidiaries.................................................................................................................16
            Head Office .......................................................................................................................................................................................................16
            Other Locations & Subsidiaries .........................................................................................................................................................................16
      Integra LifeSciences Holdings Corporation - Key Manufacturing Facilities ...............................................................................................................18
      Section 2 – Company Analysis ................................................................................................................................................................................19
      Integra LifeSciences Holdings Corporation - Business Description ..........................................................................................................................19
            Business Description - Integra Medical Instruments ..........................................................................................................................................19
                  Integra Medical Instruments - Overview ......................................................................................................................................................19
                  Integra Medical Instruments - Financials .....................................................................................................................................................19
                  Integra Medical Instruments - Market View ................................................................................................................................................19
                  Integra Medical Instruments - Technology...................................................................................................................................................19
            Business Description - Integra NeuroSciences ..................................................................................................................................................20
                  Integra NeuroSciences - Overview ..............................................................................................................................................................20
                  Integra NeuroSciences - Financials.............................................................................................................................................................20
                  Integra NeuroSciences - Market View .........................................................................................................................................................20
                  Integra NeuroSciences - Key Strategies .....................................................................................................................................................20
                  Integra NeuroSciences - Technology ..........................................................................................................................................................20
            Business Description - Integra Orthopedics .......................................................................................................................................................20
                  Integra Orthopedics - Overview..................................................................................................................................................................21
      Integra LifeSciences Holdings Corporation - SWOT Analysis ..................................................................................................................................22
            SWOT Analysis - Overview ...............................................................................................................................................................................22
            Integra LifeSciences Holdings Corporation - Strengths......................................................................................................................................22
                  Strength - Sales and Distribution Network ...................................................................................................................................................22
                  Strength - Diversified Product Base ............................................................................................................................................................22
                  Strength - Expanding Market Share in Sector .............................................................................................................................................22
                  Strength - Expanding Operating Margin ......................................................................................................................................................23
                  Strength - Efficient Use of Resources .........................................................................................................................................................23
            Integra LifeSciences Holdings Corporation - Weaknesses ................................................................................................................................23
                  Weakness - Raw Materials Derived from Animal Sources ...........................................................................................................................23
                  Weakness - Reliance on the US Market ......................................................................................................................................................23
                  Weakness - Limited Liquidity Position .........................................................................................................................................................23
                  Weakness - Product Recalls .......................................................................................................................................................................23
            Integra LifeSciences Holdings Corporation - Opportunities ................................................................................................................................23
                  Opportunity - Strategic Acquisitions and Agreements..................................................................................................................................23
                  Opportunity - Produ
				
DOCUMENT INFO
Description: Integra LifeSciences Holdings Corporation (Integra) is one of the world’s leading innovative medical device companies, focused on the development, manufacture and marketing of devices for use in cranial and spinal procedures, peripheral nerve repair, small bone and joint injuries, and the repair and reconstruction of soft tissue. The company has three business divisions, namely, Integra NeuroSciences, Integra Orthopedics and Integra Medical Instruments. The company has manufacturing and R&D facilities in the US, Puerto Rico, the UK, Ireland, France, Germany and Mexico. Its operations are spread across the US, Europe, Asia Pacific and Other foreign Regions. Integra is headquartered in New Jersey, the US. The company's strategy is to grow through acquisitions. As a part of this strategy in May 2011 the company acquired SeaSpine, Inc. and in September 2011 it acquired Ascension Orthopedics, Inc.
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.